1. Home >
  2. M&A >
  3. Venture >
  4. United States >
  5. Connecticut >
  6. Advantage Capital Partners Invests In Cybrexa Therapeutics

Investment Summary

Advantage Capital Partners Invests In Cybrexa Therapeutics

On January 1, 2018, growth capital firm Advantage Capital Partners invested in life science company Cybrexa Therapeutics

Investment Highlights
  • This is Advantage Capital Partners’ 15th transaction in the Life Science sector.
  • This is Advantage Capital Partners’ 247th transaction in the United States.
  • This is Advantage Capital Partners’ 18th transaction in Connecticut.

Investment Summary
Date 2018-01-01
Target Cybrexa Therapeutics
Sector Life Science
Investor(s) Advantage Capital Partners
Deal Type Venture

Target

Cybrexa Therapeutics

New Haven, Connecticut, United States
Cybrexa Therapeutics is developing an entirely new class of therapeutics that directly targets the tumor microenvironment. Cybrexa is an oncology-focused platform technology company that enables antigen-independent targeting of tumors and metastases with deep tissue penetration for small molecule anti-cancer drugs. Cybrexa Therapeutics was founded in 2017 and is based in New Haven, Connecticut.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Advantage Capital Partners

New Orleans, Louisiana, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1992
PE ASSETS 2.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.

DEAL STATS #
Overall 248 of 329
Sector: Life Science M&A 15 of 16
Type: Venture M&A Deals 111 of 125
State: Connecticut M&A 18 of 23
Country: United States M&A 247 of 325
Year: 2018 M&A 12 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Power Gen Components

Las Vegas, Nevada, United States

Power Gen Components is a manufacturer of precision fasteners engineered specifically for power generation and oil & gas applications. Power Gen Components was founded in 2010 and is based in Las Vegas, Nevada.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-03 C&M

Wauregan, Connecticut, United States

C&M Corp. is a designer and manufacturer of wire & cable and coil cords for performance-critical applications. The company serves blue-chip customers across a variety of growing markets including industrial automation, medical and military. C&M Corporation has over 50 years of experience designing and manufacturing wire and cable, coil cords, and cable assembly solutions for mission and performance critical applications which simply cannot fail.

Sell -
Mergr

Solution for

Product

Company

Legal